Browse by Poster Presenter

Skip to main content

ICPE 2023 Main banner

ICPE 2023 Program

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

R
Raaket, Hans Kristian

Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg
(A34) Analgesics Utilization in Danish Cystic Fibrosis Patients
Hans Kristian Raaket
Favorite
Raguideau, Fanny

Heva
(193) Use of a Clustering Algorithm for Treatment Sequences (TAK®) as a Pre-processing Step to Explanatory and Predictive Models
Fanny Raguideau
Favorite
Rahai, Neloufar

Aetion, Inc.
(129) Appropriate washout period for adverse events of special interest (AESI) in vaccine active surveillance utilizing an administrative claims database
Neloufar Rahai
Favorite
Rahman, Alvi

Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
(273) Comparing the performance of nested case-control and case-crossover study designs for assessing adverse outcomes of concomitant drug use: a simulation study
Alvi Rahman
Favorite
(C27) Concomitant use of selective serotonin reuptake inhibitors with oral anticoagulants and the risk of major bleeding in patients with atrial fibrillation
Alvi Rahman
Favorite
Rahmawati, Riana

Pharmacology Department, Faculty of Medicine, Universitas Islam Indonesia
(053) Blood Pressure Action Sheet and Medication Adherence for Hypertension: A mixed-method study in Yogyakarta, Indonesia
Riana Rahmawati
Favorite
Rajan, Asha

Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal
(132) Efficacy and safety of Remdesivir in COVID-19 patients: An overview of meta-Analysis
Asha Rajan
Favorite
Ramcharran, Darmendra

GSK
(234) An iterative phenotype development and evaluation process with medical specialist input: the experience defining progressive multifocal leukoencephalopathy
Darmendra Ramcharran
Favorite
Ramesh, Madhan

Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysore-570 015. India
(022) Assessment of Narrow therapeutic Index Drugs and Associated Drug Related Problems: A Prospective Cohort Study
Madhan Ramesh
Favorite
(028) Assessment of High-Risk Medications Utilization and Prescribing Patterns among Special Populations using WHO Prescribing Indicators
Madhan Ramesh
Favorite
(032) Drug Utilization Evaluation of Narrow Therapeutic Index Drugs in A Tertiary Care Teaching Hospital
Madhan Ramesh
Favorite
(119) Empowering the Elderly Patients: A Study on Impact of Virtual Patient Education on Medication Adherence
Madhan Ramesh
Favorite
(B09) A Hospital-Based Cohort Study on Drug-Related Problems Associated with High-Risk Medications Amongst Special Populations
Madhan Ramesh
Favorite
Rao, Meghashree

Manipal College of Pharmaceutical Sciences MAHE Manipal
(B05) Effectiveness of Medication Therapy Management in Older Adults with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meghashree Rao
Favorite
Rashidi, Emaan

IQVIA
(128) Real-World Patterns of Opioid Analgesic, Gabapentinoid, and Benzodiazepine Prescriptions in the United States: A Drug Utilization Study (2017-2021)
Emaan Rashidi
Favorite
Rashid, Muhammed

Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal
(053) Proton pump inhibitors and risk of kidney diseases: An overview of meta-analyses
Muhammed Rashid
Favorite
Rasmussen, Lotte

Syddansk Universitet
(199) Comparison of sociodemographic factors, health care utilisation by general practitioner visits and somatic hospital admissions, and medication use in Norway, Sweden, and Denmark
Lotte Rasmussen
Favorite
(275) Sex-specific prevalences of psychotropic medication in pediatric populations from DK and US: 2010-2020
Lotte Rasmussen
Favorite
Rasouliyan, Lawrence

OMNY Health
(024) Alopecia Areata Severity and Real-World Treatment Patterns
Lawrence Rasouliyan
Favorite
(062) Acne Vulgaris: Disease Severity and Real-World Treatment Patterns
Lawrence Rasouliyan
Favorite
(A40) Identifying Generalized Pustular Psoriasis Flares Using Natural Language Processing of Unstructured Clinical Notes and Structured Procedure Codes
Lawrence Rasouliyan
Favorite
(C22) Plaque Psoriasis in the Real-World Setting: Disease Activity and Initiation of Advanced Therapy
Lawrence Rasouliyan
Favorite
Rataj, Alison

UMass Chan Medical School
(111) Who You Are And Where You Are Influences Antipsychotic Use in People with Dementia Living in Nursing Homes
Alison Rataj
Favorite
Ravi, Ravina

JSS College of Pharmacy, Mysuru
(050) A Qualitative Approach in Assessing the Contributing Factors towards the Medication Error-Prone Behavior amongst the Healthcare Professionals
Ravina Ravi
Favorite
(052) Initiation and Implementation of a Medication Error Reporting and Monitoring Program: A Developing Country Scenario
Ravina Ravi
Favorite
Reefhuis, Jennita

Centers for Disease Control and Prevention
(099) Patterns of prescription medication use during pregnancy in the United States, 1997–2018
Jennita Reefhuis
Favorite
(115) Associations between Antibiotics and Non-Cardiac Birth Defects, National Birth Defects Prevention Study and Birth Defects Study to Evaluate Pregnancy Exposures
Jennita Reefhuis
Favorite
Regan, Annette

University of San Francisco, San Francisco CA, USA
(060) National U.S. Claims-Based Cohort Study of the Safety of Adenoviral Vector COVID-19 Vaccination during Pregnancy
Annette Regan
Favorite
Reichert, Heidi

EpidStrategies, a division of ToxStrategies, LLC
(095) Pilot Surveillance of Infant Lower Respiratory Tract Infections and Respiratory Syncytial Virus in the United States During the COVID Pandemic
Heidi Reichert
Favorite
Reutfors, Johan

Centre for Pharmacoepidemiology, Karolinska Institutet
(249) Validation of Diagnoses of Hepatic Disorders in Users of Systemic Antifungal Medication in Sweden
Johan Reutfors
Favorite
(296) A Post Authorization Safety Study of Long-Term Voriconazole Use in Sweden: A Population Based Cohort Study
Johan Reutfors
Favorite
Reynolds, Kamika

Sanofi
(194) Incidence of Autoimmune Diseases among Patients with Asthma in the US
Kamika Reynolds
Favorite
Rijhwani, Leena

Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
(C24) Temporal Trends in Use of Old and New Intravenous Iron Formulations among US Medicare Beneficiaries, 2008-2019
Leena Rijhwani
Favorite
Ritchey, Mary

CERobs Consulting
(228) Validity of a Claims-Based Algorithm to Identify Lactic Acidosis in US Medicare
Mary Ritchey
Favorite
Rodríguez, L. Yesenia

IETSI- ESSALUD
(251) Adverse events related to medical devices in the Social Security - EsSalud in Peru (2018-2021): a descriptive analysis of a surveillance system
L. Yesenia Rodríguez
Favorite
Rosenberg, Daniel

Janssen
(162) Rare disease observational research enabled through the federated data network approach: PHederation use case
Daniel Rosenberg
Favorite
(178) Real world evidence in Rare Disease – Application of fit for purpose data sources framework in portopulmonary hypertension
Daniel Rosenberg
Favorite
Rosen, Sarah

PPD, part of Thermo Fisher Scientific
(278) Adapting clinical endpoints to a real-world setting in vaccine effectiveness and safety studies
Sarah Rosen
Favorite
Ross, Rachael

Columbia University
(256) Leveraging External Validation Data to Address Misclassification: The Challenge of Transporting Misclassification Probabilities
Rachael Ross
Favorite
Rothnie, Kieran

GSK
(189) Development and validation of a claims-based definitional algorithm for moderate asthma exacerbations
Kieran Rothnie
Favorite
Rough, Kathryn

IQVIA
(C10) Early identification of patients at risk for Type-2 diabetes using machine learning models
Kathryn Rough
Favorite
(C16) Wearables and digital tools for infectious disease: Overview of existing digital contact tracing systems
Kathryn Rough
Favorite
Roy, Debabrata

Drug Safety Research Unit
(074) Active and Passive Safety Surveillance in Children Receiving Live Attenuated Influenza Vaccine (LAIV), in England During Early Influenza Seasons from 2014/2015 to 2021/2022
Debabrata Roy
Favorite
(177) Utilisation and Safety of IV Bolus Formulation of Akis® for use in the Prevention and Treatment of Post-operative Pain in the UK Secondary Setting
Debabrata Roy
Favorite
(278) Utilisation and safety of Glycopyrronium Bromide 1mg/5ml oral solution for sialorrhoea in the paediatric population in the UK: Interim results from a non-interventional post authorisation safety study
Debabrata Roy
Favorite
Rubin, Danielle

Milliman, Inc.
(061) Psychiatric Prescription Drug Utilization and Related Overdoses Among Commercially Insured Individuals in the United States, 2020
Danielle Rubin
Favorite
Ruppenkamp, Jill

Johnson & Johnson
(156) Anatomical Characterization of Long Bone Femur and Tibial Fractures and Associated Two-Year Risks of Non-Union – A US Database Analysis
Jill Ruppenkamp
Favorite
(171) Treatments and Healthcare Costs Associated with Long Bone Fracture Non-Union - A US Claims Database Analysis
Jill Ruppenkamp
Favorite
(173) Risk Factors Associated with Long bone Fracture Non-Union – A US Claims Database Analysis
Jill Ruppenkamp
Favorite
Russo, Massimiliano

Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics
(277) Assessing joint covariate balance in matched observational studies with high-dimensional categorical variables
Massimiliano Russo
Favorite
Rusu, Rada

Global Public Health, Johnson & Johnson Inc.
(172) A Feasibility Evaluation of US Healthcare Claims Data to Describe Patient Healthcare Utilization Patterns for Dengue Infection
Rada Rusu
Favorite